Latest research
Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.
Top papers this month · This week's roundup
Trending topics
Digital reminders (portal message, text or email) raised 14-day statin refills among 20,604 non-adherent adults from 12.0% to 14.4%. A second reminder helped non-responders; switching the channel did not.
RCTn = 20,604
Bhatt et al. Digital Outreach to Improve Statin Refills in Patients With Low Statin Adherence: The ADHERE-ASCVD Randomized Clinical TrialMeta-analysis of 29 studies (4 randomised; 5,604 adults) of suction vs traditional ureteral access sheaths in RIRS: suction probably cut residual fragments early (RR 0.49) and late (RR 0.53) and fever (RR 0.43); septic shock not clearly reduced.
Meta-analysisn = 5,604
Shiomi da Cruz et al. Suction versus traditional ureteral access sheaths in retrograde intrarenal surgery: an updated systematic review and meta-analysis of stone-free rates and complicationsIn a systematic review and meta-analysis of 10 RCTs (851 cancer survivors given cardiotoxic therapies), home-based exercise improved VO2 peak (MD 2.35 mL/kg/min) but not 6MWT or quality of life; effect on cardiotoxicity was unproven (one study).
Meta-analysisn = 851
Wang et al. Effectiveness of home-based exercise interventions on cardiorespiratory fitness and cancer treatment-related cardiovascular toxicity in cancer survivors exposed to cardiotoxic therapies: a systematic review and meta-analysis of randomized controlled trialsIn two placebo-controlled trials of 757 adults with severe hypertriglyceridaemia, quarterly plozasiran cut median fasting triglycerides by 79% and 81% at 12 months (placebo-adjusted −45 and −47 points); pooled acute pancreatitis rates were 1 vs 5 per 100 patient-years.
RCTn = 757
Watts et al. Plozasiran for Severe Hypertriglyceridemia and Risk of PancreatitisIn 463 patients over 60 with AML or high-risk MDS, adding quizartinib after intensive chemotherapy did not significantly improve overall survival (primary outcome) and raised non-relapse mortality; in a pre-planned FLT3-mutated subgroup (116), OS improved (HR 0.59).
RCTn = 463
Knapper et al. Combining quizartinib with intensive chemotherapy for older patients with newly diagnosed AML: results of the UK NCRI AML18 trialIn 430 randomised patients with breast cancer (327 assessed at 18 months), app-based CBT or mindfulness stress management did not significantly reduce perceived stress versus usual care; prespecified moderator analyses suggested benefit in women aged ≤50.
RCTn = 430
Svendsen et al. Effects of digital stress-management interventions in breast cancer patients 18 months after intervention accessIn 400 children aged 2–6 undergoing adenotonsillectomy, ventilation with a laryngeal mask airway led to fewer perioperative respiratory adverse events than an endotracheal tube (22.5% v 57.5%; risk difference −35.0 points). No serious adverse events occurred.
RCTn = 400
Han et al. Perioperative respiratory adverse events in children undergoing adenotonsillectomy with laryngeal mask airway versus endotracheal tube ventilation: multicentre, randomised controlled trialIn 381 adults with moderate-to-severe COPD at high exacerbation risk, mitiperstat 5 mg daily for up to 24 weeks did not delay first COPDCompEx event vs placebo (66.1% vs 65.1%; HR 1.07, 90% CI 0.87–1.32). Pneumonia occurred in 7 vs 2 participants.
RCTn = 381
Saralaya et al. A phase 2a, double-blind, randomised, placebo-controlled trial of the myeloperoxidase inhibitor, mitiperstat, in participants with COPDMeta-analysis of 7 studies (237 children with JIA, 132 controls): JIA was associated with more type As tympanograms (RR 13.93) and higher hearing thresholds, largest at 16 kHz (SMD 1.52); otoacoustic emission differences were non-significant.
Meta-analysisn = 369
Chen et al. Conductive and sensorineural hearing impairment in juvenile idiopathic arthritis: a systematic review and meta-analysisIn 167 obese patients after AF catheter ablation, a 15-month weight loss programme (mean 6.8% weight loss) did not reduce AF/atrial tachycardia burden vs usual care (change 0.6% vs −0.9%); recurrence-free survival was similar (70.4% vs 69.6%).
RCTn = 167
Koščálová et al. A randomized comparison of comprehensive weight loss intervention vs. usual care on recurrences of atrial fibrillation in obese patients after catheter ablation: HOBIT-AF trial